Naomi Aronson, Ph.D., is the Executive Director of Clinical Evaluation, Innovation, and Policy, Blue Cross and Blue Shield Association (BCBSA); the US' largest payer . Dr. Aronson leads BCBSA clinical effectiveness and policy engagement with government, regulatory agencies and policy consortia. Her areas of leadership include comparative effectiveness, patient centered research, safety surveillance, regulatory science and methodological standards. We caught up with her at our Miami Leaders Forum 2017 to pose some questions about technology assessment for advanced therapeutics. See more at www.phacilitate.co.uk